A scientist who works on the AstraZeneca vaccine with Oxford University in the UK has come out to defend the decision to sell its covid-19 vaccine at a profit, according to a new report from the Financial Times. AstraZeneca was previously unique because it sold the covid-19 vaccine at cost, unlike most other vaccine…
